Advertisement
U.S. markets closed

Terumo Corporation (TRUMF)

Other OTC - Other OTC Delayed Price. Currency in USD
18.55+0.19 (+1.03%)
At close: 03:53PM EDT
  • Dividend

    TRUMF announced a cash dividend of 22.00 with an ex-date of Mar. 28, 2024

  • Split

    TRUMF is splitting 2:1 effective Mar. 28, 2024

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close18.36
Open37.73
Bid0.00 x 0
Ask0.00 x 0
Day's Range18.55 - 18.62
52 Week Range12.48 - 19.84
Volume900
Avg. Volume2,218
Market Cap27.549B
Beta (5Y Monthly)0.51
PE Ratio (TTM)42.16
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield0.32 (1.75%)
Ex-Dividend DateMar 28, 2024
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for TRUMF

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • TERUMO CORP
    Analyst Report: Coloplast A/SColoplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.
    Rating
    Fair Value
    Economic Moat
    last monthMorningstar
View more